Epigenome	B:C2350277
-	I:C2350277
wide	I:C2350277
analysis	I:C2350277
links	O
SMAD3	O
methylation	O
at	O
birth	O
to	O
asthma	O
in	I:C0264408
children	I:C0264408
of	O
asthmatic	O
mothers	O
.	O

Epigenome	O
-	I:C2350277
wide	I:C2350277
analysis	I:C2350277
links	O
SMAD3	B:C0919432
methylation	O
at	O
birth	O
to	O
asthma	O
in	I:C0264408
children	I:C0264408
of	O
asthmatic	O
mothers	O
.	O

Epigenome	O
-	I:C2350277
wide	I:C2350277
analysis	I:C2350277
links	O
SMAD3	O
methylation	B:C0376452
at	O
birth	O
to	O
asthma	O
in	I:C0264408
children	I:C0264408
of	O
asthmatic	O
mothers	O
.	O

Epigenome	O
-	I:C2350277
wide	I:C2350277
analysis	I:C2350277
links	O
SMAD3	O
methylation	O
at	O
birth	B:C0005615
to	O
asthma	O
in	I:C0264408
children	I:C0264408
of	O
asthmatic	O
mothers	O
.	O

Epigenome	O
-	I:C2350277
wide	I:C2350277
analysis	I:C2350277
links	O
SMAD3	O
methylation	O
at	O
birth	O
to	O
asthma	B:C0264408
in	I:C0264408
children	I:C0264408
of	O
asthmatic	O
mothers	O
.	O

Epigenome	O
-	I:C2350277
wide	I:C2350277
analysis	I:C2350277
links	O
SMAD3	O
methylation	O
at	O
birth	O
to	O
asthma	O
in	I:C0264408
children	I:C0264408
of	O
asthmatic	B:C0004096
mothers	O
.	O

The	O
timing	O
and	O
mechanisms	O
of	O
asthma	B:C0004096
inception	O
remain	O
imprecisely	O
defined	O
.	O

Although	O
epigenetic	B:C1516924
mechanisms	O
likely	O
contribute	O
to	O
asthma	O
pathogenesis	O
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
asthma	O
inception	O
.	O

Although	O
epigenetic	O
mechanisms	O
likely	O
contribute	O
to	O
asthma	B:C0004096
pathogenesis	O
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
asthma	O
inception	O
.	O

Although	O
epigenetic	O
mechanisms	O
likely	O
contribute	O
to	O
asthma	O
pathogenesis	B:C0699748
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
asthma	O
inception	O
.	O

Although	O
epigenetic	O
mechanisms	O
likely	O
contribute	O
to	O
asthma	O
pathogenesis	O
,	O
little	O
is	O
known	O
about	O
their	O
role	O
in	O
asthma	B:C0004096
inception	O
.	O

We	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	B:C0004096
begins	O
already	O
at	O
birth	O
and	O
whether	O
epigenetic	O
mechanisms	O
,	O
specifically	O
DNA	O
methylation	I:C0376452
,	O
contribute	O
to	O
asthma	O
inception	O
.	O

We	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	O
begins	O
already	O
at	O
birth	B:C0005615
and	O
whether	O
epigenetic	O
mechanisms	O
,	O
specifically	O
DNA	O
methylation	I:C0376452
,	O
contribute	O
to	O
asthma	O
inception	O
.	O

We	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	O
begins	O
already	O
at	O
birth	O
and	O
whether	O
epigenetic	B:C1516924
mechanisms	O
,	O
specifically	O
DNA	O
methylation	I:C0376452
,	O
contribute	O
to	O
asthma	O
inception	O
.	O

We	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	O
begins	O
already	O
at	O
birth	O
and	O
whether	O
epigenetic	O
mechanisms	O
,	O
specifically	O
DNA	B:C0376452
methylation	I:C0376452
,	O
contribute	O
to	O
asthma	O
inception	O
.	O

We	O
sought	O
to	O
assess	O
whether	O
the	O
trajectory	O
to	O
asthma	O
begins	O
already	O
at	O
birth	O
and	O
whether	O
epigenetic	O
mechanisms	O
,	O
specifically	O
DNA	O
methylation	I:C0376452
,	O
contribute	O
to	O
asthma	B:C0004096
inception	O
.	O

We	O
used	O
the	O
Methylated	B:C1328856
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	B:C0038951
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	B:C0376452
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	B:C0162371
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	B:C0080105
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	B:C0004096
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	B:C0080105
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	B:C2603343
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	B:C2603343
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	B:C0005615
cohort	O
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	B:C0599755
closely	O
monitored	O
for	O
asthma	O
for	O
a	O
decade	O
.	O

We	O
used	O
the	O
Methylated	O
CpG	I:C1328856
Island	I:C1328856
Recovery	I:C1328856
Assay	I:C1328856
chip	I:C1328856
to	O
survey	O
DNA	O
methylation	I:C0376452
in	O
cord	O
blood	I:C0162371
mononuclear	O
cells	O
from	O
36	O
children	O
(	O
18	O
nonasthmatic	O
and	O
18	O
asthmatic	O
subjects	O
by	O
age	O
9	O
years	O
)	O
from	O
the	O
Infant	O
Immune	O
Study	O
(	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
)	O
,	O
an	O
unselected	O
birth	O
cohort	O
closely	O
monitored	O
for	O
asthma	B:C0004096
for	O
a	O
decade	O
.	O

SMAD3	B:C0919432
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	B:C0376452
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	B:C2603343
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	B:C0598312
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	B:C0599755
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	B:C0004096
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	B:C0264408
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	B:C2603343
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	B:C0936012
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	B:C3831347
sequencing	I:C3831347
or	O
Illumina	O
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
(	O
n	O
=	O
60	O
)	O
and	O
in	O
2	O
replication	O
cohorts	O
(	O
the	O
Manchester	O
Asthma	O
and	O
Allergy	O
Study	O
[	O
n	O
=	O
30	O
]	O
and	O
the	O
Childhood	O
Origins	I:C0264408
of	I:C0264408
Asthma	I:C0264408
Study	O
[	O
n	O
=	O
28	O
]	O
)	O
was	O
analyzed	O
by	O
using	O
bisulfite	O
sequencing	I:C3831347
or	O
Illumina	B:C0022885
450	I:C0022885
K	I:C0022885
arrays	I:C0022885
.	O

Cord	B:C0162371
blood	I:C0162371
mononuclear	O
cell	O
-	O
derived	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
levels	O
were	O
measured	O
by	O
means	O
of	O
ELISA	O
.	O

Cord	O
blood	I:C0162371
mononuclear	O
cell	O
-	O
derived	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
levels	O
were	O
measured	O
by	O
means	O
of	O
ELISA	O
.	O

Cord	O
blood	I:C0162371
mononuclear	O
cell	O
-	O
derived	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
levels	O
were	O
measured	O
by	O
means	O
of	O
ELISA	B:C0014441
.	O

Neonatal	O
immune	O
cells	B:C0007634
harbored	O
589	O
differentially	O
methylated	O
regions	I:C0004793
that	O
distinguished	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
children	O
who	O
did	O
and	O
did	O
not	O
have	O
asthma	O
by	O
age	O
9	O
years	O
.	O

Neonatal	O
immune	O
cells	O
harbored	O
589	O
differentially	O
methylated	B:C0004793
regions	I:C0004793
that	O
distinguished	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
children	O
who	O
did	O
and	O
did	O
not	O
have	O
asthma	O
by	O
age	O
9	O
years	O
.	O

Neonatal	O
immune	O
cells	O
harbored	O
589	O
differentially	O
methylated	O
regions	I:C0004793
that	O
distinguished	O
Infant	B:C2603343
Immune	I:C2603343
Study	I:C2603343
children	O
who	O
did	O
and	O
did	O
not	O
have	O
asthma	O
by	O
age	O
9	O
years	O
.	O

Neonatal	O
immune	O
cells	O
harbored	O
589	O
differentially	O
methylated	O
regions	I:C0004793
that	O
distinguished	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
children	B:C1257890
who	O
did	O
and	O
did	O
not	O
have	O
asthma	O
by	O
age	O
9	O
years	O
.	O

Neonatal	O
immune	O
cells	O
harbored	O
589	O
differentially	O
methylated	O
regions	I:C0004793
that	O
distinguished	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
children	O
who	O
did	O
and	O
did	O
not	O
have	O
asthma	B:C0004096
by	O
age	O
9	O
years	O
.	O

In	O
all	O
3	O
cohorts	B:C0599755
methylation	O
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	B:C0376452
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	O
in	O
SMAD3	B:C0919432
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	O
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	B:C0004096
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	O
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	B:C0004793
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	O
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	B:C0264408
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	O
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	B:C0004096
mothers	O
and	O
was	O
associated	O
with	O
childhood	O
asthma	I:C0264408
risk	O
.	O

In	O
all	O
3	O
cohorts	O
methylation	O
in	O
SMAD3	O
,	O
the	O
most	O
connected	O
node	O
within	O
the	O
network	O
of	O
asthma	O
-	O
associated	O
,	O
differentially	O
methylated	O
regions	I:C0004793
,	O
was	O
selectively	O
increased	O
in	O
asthmatic	O
children	O
of	O
asthmatic	O
mothers	O
and	O
was	O
associated	O
with	O
childhood	B:C0264408
asthma	I:C0264408
risk	O
.	O

Moreover	O
,	O
SMAD3	B:C0919432
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
neonates	O
with	O
maternal	O
asthma	O
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
,	O
an	O
innate	O
inflammatory	I:C0243042
mediator	I:C0243042
.	O

Moreover	O
,	O
SMAD3	O
methylation	B:C0376452
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
neonates	O
with	O
maternal	O
asthma	O
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
,	O
an	O
innate	O
inflammatory	I:C0243042
mediator	I:C0243042
.	O

Moreover	O
,	O
SMAD3	O
methylation	O
in	O
Infant	B:C2603343
Immune	I:C2603343
Study	I:C2603343
neonates	O
with	O
maternal	O
asthma	O
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
,	O
an	O
innate	O
inflammatory	I:C0243042
mediator	I:C0243042
.	O

Moreover	O
,	O
SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
neonates	O
with	O
maternal	O
asthma	B:C0004096
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
,	O
an	O
innate	O
inflammatory	I:C0243042
mediator	I:C0243042
.	O

Moreover	O
,	O
SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
neonates	O
with	O
maternal	O
asthma	O
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
,	O
an	O
innate	O
inflammatory	I:C0243042
mediator	I:C0243042
.	O

Moreover	O
,	O
SMAD3	O
methylation	O
in	O
Infant	O
Immune	I:C2603343
Study	I:C2603343
neonates	O
with	O
maternal	O
asthma	O
was	O
strongly	O
and	O
positively	O
associated	O
with	O
neonatal	O
production	O
of	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
,	O
an	O
innate	B:C0243042
inflammatory	I:C0243042
mediator	I:C0243042
.	O

The	O
trajectory	O
to	O
childhood	B:C0264408
asthma	I:C0264408
begins	O
at	O
birth	O
and	O
involves	O
epigenetic	O
modifications	O
in	O
immunoregulatory	O
and	O
proinflammatory	O
pathways	O
.	O

The	O
trajectory	O
to	O
childhood	O
asthma	I:C0264408
begins	O
at	O
birth	B:C0005615
and	O
involves	O
epigenetic	O
modifications	O
in	O
immunoregulatory	O
and	O
proinflammatory	O
pathways	O
.	O

The	O
trajectory	O
to	O
childhood	O
asthma	I:C0264408
begins	O
at	O
birth	O
and	O
involves	O
epigenetic	B:C1516924
modifications	O
in	O
immunoregulatory	O
and	O
proinflammatory	O
pathways	O
.	O

The	O
trajectory	O
to	O
childhood	O
asthma	I:C0264408
begins	O
at	O
birth	O
and	O
involves	O
epigenetic	O
modifications	O
in	O
immunoregulatory	B:C0678889
and	O
proinflammatory	O
pathways	O
.	O

The	O
trajectory	O
to	O
childhood	O
asthma	I:C0264408
begins	O
at	O
birth	O
and	O
involves	O
epigenetic	O
modifications	O
in	O
immunoregulatory	O
and	O
proinflammatory	O
pathways	B:C1704259
.	O

Maternal	O
asthma	B:C0004096
influences	O
epigenetic	O
mechanisms	O
that	O
contribute	O
to	O
the	O
inception	O
of	O
this	O
trajectory	O
.	O

Maternal	O
asthma	O
influences	O
epigenetic	B:C1516924
mechanisms	O
that	O
contribute	O
to	O
the	O
inception	O
of	O
this	O
trajectory	O
.	O

